PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

PANACEA LIFE SCIENCES HOLDINGS, INC.

Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024

$0.07+0.00 (+5.45%)

Close on Oct 19, 2026

Community

Notes and questions about Panacea Life Sciences from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Panacea Life Sciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-28 reverse split on Nov 22, 2021
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PLSH.

Revenue growth50.4% · median 9.1%

Gross margin56.5% · median 32.0%

Operating margin-192.2% · median -8.7%

Net margin-277.5% · median -14.0%

Advertisement
300 × 250